amantadine has been researched along with Hepatolenticular Degeneration in 2 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Hepatolenticular Degeneration: A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Webster, DD | 1 |
| Mortimer, JA | 1 |
| Berio, A | 1 |
| Vento, R | 1 |
| Di Stefano, A | 1 |
2 other studies available for amantadine and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Failure of L-dopa to relieve activated rigidity in Parkinson's disease.
Topics: Adult; Amantadine; Extrapyramidal Tracts; Hepatolenticular Degeneration; Humans; Levodopa; Male; Mid | 1977 |
[Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease].
Topics: Adolescent; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Hepatolenticular Degeneratio | 1973 |